Status:
COMPLETED
Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt
Lead Sponsor:
Ministry of Health and Population, Egypt
Conditions:
Convalescent Plasma
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
One investigational treatment being explored for COVID-19 is the use of convalescent plasma collected from individuals who have recovered from COVID-19 (Refs. 1-4). Convalescent plasma that contains a...
Detailed Description
laboratory-confirmed patients using qRT-PCR will be enrolled in the study. Eligibility criteria for recipients are ; laboratory-confirmed SARS-CoV-2, Severe or immediately life-threatening. Severe dis...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Laboratory confirmed COVID-19. Severe or immediately life-threatening COVID-19,
- Exclusion Criteria Not fitting inclusion criteria
Exclusion
Key Trial Info
Start Date :
April 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2020
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04816942
Start Date
April 23 2020
End Date
October 12 2020
Last Update
March 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministry of Health
Cairo, Giza Governorate, Egypt, 00202